Formulations containing anti VEGF molecules and a fluoru00d3foro for application in ocular pathologies

摘要

The Invention relates to a formulation of bevacizumab and Fluorescein isocyanate for Implementation in Early Detection of Eye diseases that have high levels of VEGF and Diabetic Retinopathy, retinal Vein Occlusion, retinopathy of prematurity, Dege Age related macular Generation, etc.Moreover, This formulation is useful to guide Therapy and laser monitoring of pathology Cor Respondent.